Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The proxy should be filed soon and phase 3 should be initiated in March 2021 & phase 2 Covid 19 trial should start in April
I think so. $CYTO valuation is going to be anywhere 1B -5B, depending on trials read out. $mrk spend 1.85B for early stage pipeline and cyto have 4 phase 3 trials planned
Going up, market makers are loaded up already.
Okay! They took your numbers seriously. Lol you have 15 followers in 15 years. Lol you are clueless about biotech stocks. Move on man. This my last response to you.
Lol max has 15K followers.
Lol someone agreed with my analysis. I found very interesting tweet.
$CBLI up 30% on merger news and new company $CYTO now valued about 320M fully diluited
Come on $ARPO $MLND $ABIO $STSA $SYN ....
Lol it’s time for the convertible debt holder to convert more debt into shares
Damn it! I hate it been right. Is going back below .01
Dude! You don’t getting. I’m done explaining to you.
Come on man! Your calculations are completely wrong again.
Cyto will receive 26.64M shares & IMUN will receive 9-13.5%
26.64 *.09= 2.397M IMUN *$6=$14.4M
26.64*.10=2.664M IMUN *$6=$16M
26.64*.11=2.930M IMUN *6=$17.6M
26.64*.12=3.2M IMUN *6=$19.20M
26.64*.135=3.6M IMUN *6=$21.6M/476M os =.045 IMUN current valuation.
Yes, people are loading up. Current equity stakes on cyto are over $22M, and IMUN market cap is below $10M
Wow 1.4m bid order at .017, some one is loaded up
Absolutely! Also preclinical promising results in Covid 19. Very bullish on stock.
Clearly don’t understand pennies stock. Don’t get to excited because the price dropped.
Absolutely! Pure manipulation by market makers
Off course it’s for some one who is clueless about biotech industry
Based on data and recent acquisition. autoimmune diseases huge market opportunities MS, Crohn's over 50B market opportunities
Possible look at some recent acquisition. Momenta Pharmaceuticals acquired by JNJ for 6.5 Billion developing autoimmune diseases drug
If both trials reads out positive we could see the valuation jump 5, SP $112, probably buy out 10B. Crohn's Disease $20B market opportunities
Lol what different does make. IMUN share holder are also cyto shareholder
Cyto shareholder are also IMUN shareholder.
Okay good point. IMUN success depends on CBLI & cyto and current price have absolutely nothing to do what actual value of IMUN is. FYI shell company aabb jumped from .003 to .60 in 1 month.
Depends on phase 2 Covid 19 & phase 3 Crohn's trials. If these trials readout positive we could see the valuation 3-5B
I agree with that.
Depends on the phase 3 trial results, if phase 3 reads out positive the market cap could jump in 3B. Is time to loaded up on IMUN
Hopefully IMUN merger with OYAGEN.
No my friend. IMUN equity stake on cyto can’t drop below 13.5%
Dilution? Which company. Big order went through 1.35M
Dilution? Which company
Lol market most of time gets wrong for example Nvax 21B Market cap and dropped into 13B market cap in few weeks. I like the company and tremendously undervalued.
Current valuation is below the Consensus. The valuation should be around $1B+, after the merger. also I increased the OS just in case bond holders converted the debt into shares. CBLI is tremendously undervalued
Let assume the CBLI price is $6.10 *3.3M =20M x 5 or 7 multiplier. I Would value IMUN equity stake after the merger 100-140M /500M os -20M debt = .16-.24 per share
I would calculated 26.64M shares *13.5% or 15% =3.6-4M shares. I would like to lower to 3.3M shares just to play safe.
Yes, when the merger closed IMUN will receive actual shares. I would guess roughly 3.2-3.4M shares and it will file 13G after the shares are distributed to cyto.
IMUN current valuation on CYTOCOM is roughly $23-24M, and current market cap $10M. Tremendously undervalued
I give up. Clearly you don’t understand. FYI today volume is an indication that bond holder conversion happened. Good luck to you.
From 13D filed by institutional investors
Guessing and estimating is not the right way to do business. The company aka GC never been transparent about financials. He has con many bond holders/ investors.
SEC filing
Purpose of Transaction
The Investment Entity, by virtue of the Assignment, acquired most of the Securities during 2015 and 2018, based on what are believed to be a series of misstatements and over-aggressive representations by the Issuer’s Chief Executive Officer Gerald Commissiong. The Reporting Persons believe that the subsequent decision of the Issuer to suspend its reporting obligations provided the Issuer to undertake a dramatic effort to divert corporate opportunities from the Issuer to other companies in which Mr. Commissiong had an interest, thus depriving the Reporting Persons and other creditors and shareholders the ability to receive value and a return on invested capital in the Issuer.
Lol convertible debt is completely different than public offering. Also he never disclosed how much is left and we are in March and company hasn’t released 4QTR financials